Institutional investors purchased a net $1.3 million shares of PCYC during the quarter ended September 2014. This may signal that the smart money is gaining interest in this company as the 76.84% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BENNETT LAWRENCE MANAGEMENT LLC Bought 16.7 Thousand shares of Pharmacyclics Inc
WEAVER C. BARKSDALE & ASSOCIATES... Bought 15.4 Thousand shares of Pharmacyclics Inc